Edition:
United States

Profile: Atcor Medical Holdings Ltd (ACG.AX)

ACG.AX on Australia Stock Exchange

0.04AUD
25 May 2017
Change (% chg)

$-0.00 (-2.44%)
Prev Close
$0.04
Open
$0.04
Day's High
$0.04
Day's Low
$0.04
Volume
493,984
Avg. Vol
263,953
52-wk High
$0.14
52-wk Low
$0.04

AtCor Medical Holdings Ltd is engaged in the designing, manufacturing and marketing of medical devices for use in cardiovascular management. The Company operates through three segments: Americas, which includes global pharmaceutical trials business; Europe, which includes Middle East and Africa, and Asia Pacific, which includes Asia and Australia/New Zealand. The Company's clinical trial services, include study protocol assistance, study-specific user manual, operator training and certification, study-specific training materials, automated data transfer for expert over-read, quality assurance, ongoing data management, technical support and sponsor-defined data transfers. The Company also offers SphygmoCor technology, which is used in clinical trials for a range of therapeutic areas, including hypertension, renal disease, heart failure, inflammatory processes, diabetes and chronic obstructive pulmonary disease (COPD).

Company Address

Atcor Medical Holdings Ltd

U 11 1059 Victoria Rd
SYDNEY   NSW   2114

Company Web Links